EssilorLuxottica Net Cash Flow 2011-2024 | ESLOY

EssilorLuxottica net cash flow for the twelve months ending December 31, 2024 was $-1.386B, a 127.73% increase year-over-year.

  • EssilorLuxottica annual net cash flow for 2024 was $-0.332B, a 151.33% decline from 2023.
  • EssilorLuxottica annual net cash flow for 2023 was $0.647B, a 146.08% decline from 2022.
  • EssilorLuxottica annual net cash flow for 2022 was $-1.404B, a 77.98% decline from 2021.

EssilorLuxottica Net Cash Flow 2011-2024 | ESLOY

  • EssilorLuxottica annual net cash flow for 2024 was $-0.332B, a 151.33% decline from 2023.
  • EssilorLuxottica annual net cash flow for 2023 was $0.647B, a 146.08% decline from 2022.
  • EssilorLuxottica annual net cash flow for 2022 was $-1.404B, a 77.98% decline from 2021.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$228.8B
Boston Scientific (BSX)$156.9B
Stryker (SYK)$150.3B
Medtronic (MDT)$118.1B
Lonza Group Ag (LZAGY)$50B
Haleon (HLN)$43.5B
ResMed (RMD)$41.3B
GE HealthCare Technologies (GEHC)$33.9B
Agilent Technologies (A)$33.7B
Terumo (TRUMY)$26.9B
Koninklijke Philips (PHG)$26.7B
Insulet (PODD)$23.5B
Zimmer Biomet Holdings (ZBH)$21.2B
Smith & Nephew SNATS (SNN)$16.3B
Baxter (BAX)$12.6B
Sunny Optical Technology (SNPTF)$10.8B
Demant (WILYY)$8.1B
Bio-Rad Laboratories (BIO)$7.9B
Lantheus Holdings (LNTH)$3.9B
Envista Holdings (NVST)$3.5B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
Prestige Consumer Healthcare (PBH)$3.3B
Perrigo (PRGO)$3.3B
ICU Medical (ICUI)$3.1B
Haemonetics (HAE)$2.7B
LeMaitre Vascular (LMAT)$2.2B
Curaleaf Holdings (CURLF)$2.1B
Acuren (TIC)$2.1B
QuidelOrtho (QDEL)$1.9B
Green Thumb Industries (GTBIF)$1.9B